
A whale adds more chips
Hrt Financial LP, which already owns a big chunk of Onconetix, decided to keep leaning in. According to a Form 4 filing, the firm bought 166,904 Class A shares across two trades on April 14 and April 15 for roughly $127,590.
That works out to prices of $0.77 and $0.76 a share — basically pocket-change territory, which is also a pretty good reminder of just how beaten up this stock is. ONCO was trading around $0.76, hovering near its 52-week low of $0.67.
Why investors should care
Insider or large-holder buying can sometimes be a signal that the people closest to the business think the market’s missing something. Or it can simply mean a holder wants to maintain or increase control. Either way, when a ten percent owner keeps buying while the stock is sitting in the bargain bin, traders tend to perk up.
The fine print
- Hrt Financial now directly owns 197,052 shares after the purchases.
- The buys were disclosed in a Form 4, so this is real, fresh, and dateable — not just some leftover filing dust.
- That said, this is still a tiny-dollar transaction in absolute terms, so don’t go treating it like a billion-dollar takeover signal.
Big picture: Onconetix is getting a little extra confidence from a big shareholder, but the market will still want a lot more than a few hundred grand in buying before it starts throwing confetti.
